Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Waldenstrom Macroglobulinemia
Related studies linked through entity extraction aliases.
Nemtabrutinib, Bortezomib, and Rituximab for WM
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
- Status
- RECRUITING
- Phase
- NA
Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
- Status
- RECRUITING
- Phase
- PHASE2
Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SynKIR-310 for Relapsed/Refractory B-NHL
- Status
- RECRUITING
- Phase
- PHASE1
Epcoritamab in Previously Treated WM
- Status
- RECRUITING
- Phase
- PHASE2
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
- Status
- RECRUITING
- Phase
- N/A
Optical Coherence Tomography (OCT) and OCT Angiography(OCTA) Deep Learning in Waldenström's Macroglobulinemia Patients
- Status
- COMPLETED
- Phase
- N/A
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM
- Status
- RECRUITING
- Phase
- PHASE2
Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
- Status
- RECRUITING
- Phase
- PHASE2
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
- Status
- RECRUITING
- Phase
- N/A
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Study of SGR-1505 in Mature B-Cell Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Loncastuximab Tesirine in WM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2